지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.7
- 수록면
- 967 - 971 (5page)
- DOI
- 10.4143/crt.2023.1308
이용수
초록· 키워드
오류제보하기
SMARCB1 or SMARCA4-deficient sinonasal carcinoma or thoracic undifferentiated tumor has aggressive nature with a poor prognosis. Patients with this disease were diagnosed by immunohistochemistry or next-generation sequencing. Those who were able to receive a surgery tended to be cured, while the others treated with chemotherapy, radiation therapy, or immune checkpoint inhibitor were often insensitive to these therapies. However, one having CD274 (PD-L1) amplification showed the response to immune checkpoint inhibitor and a good prognosis. We believed that this report could provide promising information for determining the optimal treatment option.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
SMARCB1-Deficient Sinonasal Carcinoma–A Case Report and Literature Review
대한이비인후-두경부외과학회지
2024 .03
-
SMARCA4/BRG1 protein-deficient thoracic tumors dictate re-examination of small biopsy reporting in non?small cell lung cancer
Journal of Pathology and Translational Medicine
2021 .09
-
Malignant rhabdoid tumor of the kidney in an adult with loss of INI1 expression and mutation in the SMARCB1 gene
Journal of Pathology and Translational Medicine
2021 .01
-
Hyperglycemia-Suppressed SMARCA5 Disrupts Transcriptional Homeostasis to Facilitate Endothelial Dysfunction in Diabetes
Diabetes and Metabolism Journal
2023 .05
-
Undifferentiated Carcinoma of the Gallbladder : Report of Three Cases
대한외과학회 학술대회 초록집
2017 .11
-
비강 하비갑개에서 기원한 미분화암종 1예
대한이비인후-두경부외과학회지
2015 .01
-
What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
Journal of Pathology and Translational Medicine
2022 .03
-
Coffin-Siris Syndrome: Genotype-Phenotype Clustering and Novel Variants
Laboratory Medicine Online
2023 .04
-
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Tuberculosis and Respiratory Diseases
2018 .01
-
The Position of Multikinase Inhibitors in the Era of Immune-Checkpoint Inhibitors for Hepatocellular Carcinoma
Gut and Liver
2024 .01
-
Clinical experience of immune checkpoint inhibitor for a metastatic jejunal cancer patient with a high tumor mutational burden and low expression of programmed death-ligand 1
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2020 .06
-
Intracranial Undifferentiated Sarcoma Arising from a Low-Grade Glioma : A Case Report and Literature Review
대한신경외과학회지
2015 .01
-
Dismal Prognosis of Undifferentiated Pancreatic Carcinoma after Pancreatectomy: Resect or Not?
대한외과학회 학술대회 초록집
2020 .11
-
TTF1-positive SMARCA4/BRG1 deficient lung adenocarcinoma
Journal of Pathology and Translational Medicine
2022 .01
-
Immune-related Adverse Events: Overview and Management Strategies for the Use of Immune Checkpoint Inhibitors
대한류마티스학회지
2019 .01
-
Exploring histological predictive biomarkers for immune checkpoint inhibitor therapy response in non–small cell lung cancer
Journal of Pathology and Translational Medicine
2024 .03
-
Endoscopic Resection of Undifferentiated-type Early Gastric Cancer
Journal of Gastric Cancer
2020 .01
-
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Cancer Research and Treatment
2022 .10
-
Checkpoint-inhibition in ovarian cancer: rising star or just a dream?
Journal of Gynecologic Oncology
2018 .01
-
Differential response to immune checkpoint inhibitor in syngeneic gastric cancer mouse models
대한임상종양학회 학술대회지
2022 .02
최근 본 자료
댓글(0)
0